Clin2
NCT03976180Possibly a fitRecruiting

High-flow oxygen for painful sickle cell episodes

Sickle Cell Disease

Part of Blood & lymphatic, Genetic & congenital clinical trials.

This trial tests whether giving high-flow oxygen can help treat a painful sickle cell “vaso-occlusive crisis” (VOC) and lower the risk of a serious lung complication. You may be eligible if you’re an adult with sickle cell disease experiencing an opioid-requiring pain flare and have higher risk for lung trouble.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
350 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old
  • You have major sickle cell disease (SS, SC, or S-beta zero/plus types)
  • You are having an acute pain episode (VOC) that needs opioid pain medicine
  • You are at higher risk for a lung complication (based on blood counts and certain exam findings, or partly based on hydroxyurea use)
  • You can give informed consent (and meet local social security/coverage rules)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07498309Not yet recruiting· Phase 3
Iloprost for sickle cell pain crisis

This trial tests a medicine called iloprost, given through an IV, to see if it can help relieve the pain of a sickle cell crisis. If you are hospitalized for a crisis, this treatment may speed up your recovery and reduce pain.

Rouen
NCT05431088Recruiting· Phase 2/Phase 3
Study of osivelotor for sickle cell disease

This study tests an investigational medicine called osivelotor for people with sickle cell disease (SCD). The goal is to see if it can reduce pain crises and improve overall health. It is for adults and adolescents aged 12 and older.

Mobile, Alabama
NCT06989567Not yet recruiting· Phase 3
L-citrulline for sickle cell pain crises

This trial tests an intravenous medicine called L-citrulline for young people with sickle cell disease who are in the emergency department for a painful crisis (vaso-occlusive crisis). It aims to see if it can ease the pain and help you recover faster.

Washington D.C., District of Columbia
NCT06635902Recruiting· Phase 2
Citrulline for sickle cell pain crisis

This trial tests if an intravenous medication called L-citrulline can help treat pain crises in children and young adults with sickle cell disease. Participants receive either the study drug or a placebo while in the hospital for a severe pain episode.

Washington D.C., District of Columbia
NCT06755385Not yet recruiting
Ultrasound of the lungs for sickle cell pain crises

This study tests whether using ultrasound at the beside can help doctors see lung problems early in people with sickle cell disease who are having a severe pain crisis. The goal is to improve care and catch complications sooner.

NCT07826988Not yet recruiting· Phase 4
Comparing pain medicines for sickle cell crisis in hospital

This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.

Hear when a new Sickle Cell Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.